Results 141 to 150 of about 20,820 (198)

Impact of stopping Tenofovir disoproxil fumarate at various times on elevated postpartum ALT levels and breastfeeding in pregnant women with chronic hepatitis B: a prospective observational cohort study. [PDF]

BMC Pregnancy Childbirth
Li S, Jiang Y, Shi J, Jiang X, Li Y, Ma Z, Jin J.   +6 more
europepmc   +1 more source

Tenofovir alafenamide is superior to tenofovir disoproxil fumarate and entecavir in cost-effectiveness of treatment of chronic hepatitis B in china with new volume-based procurement policy. [PDF]

PLoS One
Lin Y, Lin X, Xia R, Chen J, Lin Z, Lu S.   +5 more
europepmc   +1 more source

Switching to besifovir in patients with chronic hepatitis B receiving tenofovir disoproxil fumarate: A randomized trial. [PDF]

Clin Mol Hepatol
Yim HJ, Seo YS, Kim JH, Kim W, Jung YK, Jang JY, Lee SH, Kim YS, Kim CW, Kim HS, Shim JJ, Cho EY, Kim IH, Lee BS, Lee JH, Kim BS, Jang JW, Lee HW, Kwon JH, Kim MY, Song DS, Park JG, Lee YS, Yoon EL, Lee HA, Kang SH, Yang JM.   +26 more
europepmc   +1 more source

Cost-effectiveness of tenofovir disoproxil fumarate prophylaxis for perinatal hepatitis B virus prevention in Ethiopia: a decision analytical modeling. [PDF]

BMC Public Health
Negasa AG, Bobo FT, Falta DF, Chala TK, Bayou NB.   +4 more
europepmc   +1 more source

Clinical effectiveness of entecavir versus tenofovir disoproxil fumarate tablets in chronic hepatitis B treatment. [PDF]

Am J Transl Res
Zhou Y, Shen Y, He J, Yang X.
europepmc   +1 more source

A comparison of the therapeutic efficacy of Tenofovir Disoproxil Fumarate and Entecavir in patients with chronic Hepatitis-B. [PDF]

Pak J Med Sci
Wang H, Wu L.
europepmc   +1 more source

Tenofovir disoproxil fumarate versus entecavir on the prognosis of hepatitis B virus-related hepatocellular carcinoma after surgical resection: a systematic review and meta-analysis. [PDF]

Front Oncol
Wang Y, Wu JY, Xiang Q, Liao TF, Jiang XY, Chen J.   +5 more
europepmc   +1 more source

Bone Mineral Density Changes in People with HIV Who had Immediate Switch Versus Deferred Switch from Tenofovir Disoproxil Fumarate-Based Regimens to Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Multicenter, Open-Label, Randomized Clinical Trial. [PDF]

Infect Dis Ther
Shao Y, Yang X, Yu J, Wang X, Wang J, Liu M, Yang Z, Han J, Zhang R, Liu L, Shen Y, Sun M, Wu L, Zheng Z, Tang Y, Yang J, Wang Z, Qi T, Xu S, Xun J, Sun J, Song W, Chen J.   +22 more
europepmc   +1 more source

Factors predicting renal impairment associated with Tenofovir Disoproxil fumarate: Focus on patients with HIV and pre-existing metabolic abnormalities under the Thai National Health Security Scheme. [PDF]

Prev Med Rep
Duangrithi D, Silathong K.
europepmc   +1 more source

Bone loss in young adults with HIV following antiretroviral therapy containing tenofovir disoproxil fumarate regimen using machine learning. [PDF]

Front Pharmacol
Chen L, Tang J, Zhang L, Zheng L, Wang F, Guo F, Han Y, Song X, Lv W, Cao W, Li T.   +10 more
europepmc   +1 more source